Since I believe Simpson is a straight shooter on the clinical trials, my concern is enrollment issues which could be entirely legit but ugly and hidden from view. For now, being a percentage guy 75 percent chance phase 3 successfully ended by end of 2019.
Give note to the fact that funding issues have had a negative impact on the trial.
News 
Market Data 
Discover 
AI
